NF-2 is the most commonly associated gene associated with meningioma oncogenesis, with 50–60% of meningiomas having either an inactivating NF-2 mutation or monosomy of chromosome 22 with resultant loss of an NF-2 gene [28,31]. The gene discussed is NF2; the disease is meningioma.